首页 | 本学科首页   官方微博 | 高级检索  
     


The Cost of Complications Following Major Resection of Malignant Neoplasia
Authors:Cheryl K. Zogg  Taylor D. Ottesen  Kareem J. Kebaish  Anoop Galivanche  Shilpa Murthy  Navin R. Changoor  Donald L. Zogg  Timothy M. Pawlik  Adil H. Haider
Affiliation:1.Yale School of Medicine,New Haven,USA;2.Center for Surgery and Public Health, Harvard Medical School and Harvard T.H. Chan School of Public Health, Department of Surgery,Brigham and Women’s Hospital,Boston,USA;3.Department of Surgery,Indiana University School of Medicine,Indianapolis,USA;4.Minnesota Gastroenterology, P.A.,Saint Paul,USA;5.Department of Surgery,The Ohio State University Wexner Medical Center,Columbus,USA
Abstract:

Background

Rising healthcare costs have led to increased focus on the need to achieve a higher “value of care.” As value-maximization efforts expand to include more complex surgical patients, evidence to support meaningful implementation of complication-based initiatives is lacking. The objective of this study was to compare incremental costs of complications following major gastrointestinal (GI) resections for organ-specific malignant neoplasia using nationally representative data.

Methods

National (Nationwide) Inpatient Sample data, 2001–2014, were queried for adult (≥?18 years) patients undergoing major resections for malignant neoplasia. Based on system-based complications considered relevant to the long-term treatment of GI disease, stratified differences in risk-adjusted incremental hospital costs and complication probabilities were compared. Differences in surgical outcomes and costs over time were also assessed.

Results

A total of 293,967 patients were included, weighted to represent 1,408,117 patients nationwide. One fourth (26.1%; 95% CI, 25.7–26.4%) experienced ≥?1 pre-discharge complication (range, 45.3% esophagectomy to 24.0% rectal resection). Resultant annual risk-adjusted incremental hospital costs totaled $540 million nationwide (19.5% of the overall cost of care and an average of $20,900 per patient). Costs varied substantially with both cancer/resection type and complication group, ranging from $76.7 million for colectomies with infectious complications to $0.2 million for rectal resections with urinary complications. For each resection type, infectious ($154.7 million), GI ($85.5 million), and pulmonary ($77.9 million) complications were among the most significant drivers of increased hospital cost.

Conclusions

Quantifying and comparing the impact of complications on an indication-specific level in more complex patients offers an important step toward allowing providers/payers to meaningfully prioritize the design of novel and adaptation of existing value-maximization approaches.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号